Savara (SVRA) Total Debt (2015 - 2026)
Savara (SVRA) reported Total Debt of $30.1 million for Q1 2026, up 1.84% year-over-year from $29.5 million in Q1 2025, and up 0.53% on a QoQ basis from $29.9 million in Q4 2025.
Savara (SVRA) has 12 years of Total Debt data on file, last reported at $30.1 million in Q1 2026.
- Quarterly Total Debt rose 1.84% year-over-year to $30.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.1 million (up 1.84% YoY) and the FY2025 annual result came in at $29.9 million, up 12.35% from the prior year.
- Total Debt advanced to $30.1 million in Q1 2026 per SVRA's latest filing, from $29.9 million in the prior quarter.
- Across five years, Total Debt topped out at $30.1 million in Q1 2026 and bottomed at $25.8 million in Q1 2022.
- The 5-year median for Total Debt is $26.4 million (2024), against an average of $27.3 million.
- The widest annual swing landed in 2024, when Total Debt gained 1.03%; it then gained 12.35% in 2025.
- Tracing SVRA's Total Debt over 5 years: stood at $26.1 million in 2022, then climbed by 1.04% to $26.3 million in 2023, then gained by 1.03% to $26.6 million in 2024, then gained by 12.35% to $29.9 million in 2025, then rose by 0.53% to $30.1 million in 2026.
- Per Business Quant, the three latest SVRA Total Debt figures stand at $30.1 million (Q1 2026), $29.9 million (Q4 2025), and $29.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - | 30.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.07 Mn |
| Dec 31, 2025 | 29.91 Mn |
| Sep 30, 2025 | 29.78 Mn |
| Jun 30, 2025 | 29.65 Mn |
| Mar 31, 2025 | 29.52 Mn |
| Dec 31, 2024 | 26.62 Mn |
| Sep 30, 2024 | 26.55 Mn |
| Jun 30, 2024 | 26.48 Mn |
| Mar 31, 2024 | 26.42 Mn |
| Dec 31, 2023 | 26.35 Mn |
| Sep 30, 2023 | 26.28 Mn |
| Jun 30, 2023 | 26.21 Mn |
| Mar 31, 2023 | 26.15 Mn |
| Dec 31, 2022 | 26.08 Mn |
| Sep 30, 2022 | 26.01 Mn |
| Jun 30, 2022 | 25.94 Mn |
| Mar 31, 2022 | 25.81 Mn |
| Dec 31, 2021 | 25.66 Mn |
| Sep 30, 2021 | 25.52 Mn |
| Jun 30, 2021 | 25.38 Mn |
| Mar 31, 2021 | 25.24 Mn |
| Dec 31, 2020 | 25.10 Mn |
| Sep 30, 2020 | 24.98 Mn |
| Jun 30, 2020 | 24.86 Mn |
| Mar 31, 2020 | 24.73 Mn |
| Dec 31, 2019 | 25.11 Mn |
| Sep 30, 2019 | 24.96 Mn |
| Jun 30, 2019 | 24.82 Mn |
| Mar 31, 2019 | 24.68 Mn |
| Dec 31, 2018 | 24.53 Mn |
| Sep 30, 2018 | 15.11 Mn |
| Jun 30, 2018 | 15.00 Mn |
| Mar 31, 2018 | 14.88 Mn |
| Dec 31, 2017 | 14.78 Mn |
| Sep 30, 2017 | 14.68 Mn |
| Jun 30, 2017 | 14.58 Mn |
| Mar 31, 2017 | 3.51 Mn |
| Dec 31, 2016 | 3.83 Mn |
| Sep 30, 2016 | 14.21 Mn |
| Jun 30, 2016 | 14.97 Mn |
| Mar 31, 2016 | 14.82 Mn |
| Dec 31, 2015 | 14.72 Mn |
| Sep 30, 2015 | 14.49 Mn |
| Jun 30, 2015 | 25,000.00 |
| Mar 31, 2015 | 27,000.00 |